HbA1c is a blood test that estimates longer-window glycemic exposure by measuring the percentage of hemoglobin in red blood cells that has glucose attached.
Why it matters
HbA1c is slower than fasting glucose. It reflects a multi-week to roughly three-month pattern rather than one morning. That makes it useful for long-horizon metabolic review, but it also means short experiments can be invisible if they are too brief or too small.
What can distort it
HbA1c depends on red blood cell lifespan and hemoglobin biology. Recent blood loss, donated or received blood, hemolysis, some anemias, kidney disease, pregnancy, and certain hemoglobin variants can make the number less representative of true glucose exposure. In those cases, a clinician may compare it with fasting glucose, oral glucose testing, fructosamine, CGM, or other context.
Stack interpretation
Lifestyle, medication, sleep, weight change, nutrition pattern, and adherence usually dominate HbA1c movement. Supplements such as berberine, cinnamon, or fiber products can be logged, but Unfair should not treat one HbA1c change as proof that a single ingredient worked. The signal belongs in the same evidence frame as effect size and study quality.
How to read a delta
The most useful comparison is same lab, same units, and enough time between draws for red blood cells to reflect the intervention window. A mismatch between HbA1c and fasting glucose is not rare, and it is a reason to check the measurement context rather than force a simple story.
How this appears in Unfair
HbA1c appears in the metabolic row of a blood biomarker panel. It is charted as a slow marker, so recommendation ranking should not overreact to it during a short stack cycle.
Clinical safety note
Do not use HbA1c alone to self-diagnose or self-treat diabetes. Any abnormal or discordant result should be interpreted with a clinician, especially when anemia, pregnancy, kidney disease, or recent blood loss is present.